MP
Mangattu Paramb Saifudheen
About Mangattu Paramb Saifudheen
Data last updated:
Mangattu Paramb Saifudheen is a Director at Herline Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Herline Pharmaceuticals Private Limited reported revenue of ₹77.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Herline Pharmaceuticals Private Limited U47721KL2023PTC082051 | Director | 22 Jun 2023 | 2023 | ₹77.1 Lakh (FY 2025) | Active |
Board colleagues of Mangattu Paramb Saifudheen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rejitha Muriatt Arakkal | 10210937 | Herline Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mangattu Paramb Saifudheen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mangattu Paramb Saifudheen
Mangattu Paramb Saifudheen currently holds 1 directorship: Herline Pharmaceuticals Private Limited (Director, since 22 Jun 2023, revenue ₹77.1 Lakh (FY 2025)).
Mangattu Paramb Saifudheen was first appointed on 22 Jun 2023 as Director at Herline Pharmaceuticals Private Limited.
The current boards of Mangattu Paramb Saifudheen's companies include Rejitha Muriatt Arakkal (Herline Pharmaceuticals Private Limited).